9 10, 2018 Simona Osella Abate et. al, ALK expression favorably impacts the prognosis of NRAS?mutated metastatic melanomas Diatech Pharmacogenetics2018-12-04T12:47:57+01:00 Leggi di più
1 10, 2018 Stefano Pizzolitto et. al, An unusual case of squamous cell carcinoma of the right colon Diatech Pharmacogenetics2018-12-04T12:34:29+01:00 Leggi di più
31 07, 2018 Imerio Angriman et. al, Effects of immune suppression for transplantation on inflammatory colorectal cancer progression Diatech Pharmacogenetics2018-08-27T12:58:50+02:00 Leggi di più
26 06, 2018 Iván Prieto Potin et. al, Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer Diatech Pharmacogenetics2018-08-27T13:18:01+02:00 Leggi di più
19 06, 2018 Luca Reggiani Bonetti et. al, Clinical Impact and Prognostic Role of KRAS/BRAF/PIK3CA Mutations in Stage I Colorectal Cancer Diatech Pharmacogenetics2018-08-27T12:54:22+02:00 Leggi di più
2 06, 2018 Jasna Metovic et. al, Safe transportation of formalin-fixed liquid-free pathology specimens Diatech Pharmacogenetics2018-06-05T09:58:38+02:00 Leggi di più
23 05, 2018 Sabrina Arena et. al, Characterization of tumor-derived mesenchymal stem cells potentially differentiating into cancer-associated fibroblasts in lung cancer Diatech Pharmacogenetics2018-05-30T15:25:25+02:00 Leggi di più
6 04, 2018 Valeria Maffeis et. al, Onycholemmal carcinoma: A case report with its molecular profiling Diatech Pharmacogenetics2018-04-12T15:41:02+02:00 Leggi di più
31 01, 2018 Fabrizio Tabbò et. al, Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma Diatech Pharmacogenetics2018-03-08T13:51:25+01:00 Leggi di più
15 01, 2018 Veronique Tack et. al, RAS testing for colorectal cancer patients is reliable in European laboratories that pass external quality assessment Diatech Pharmacogenetics2018-04-12T14:36:49+02:00 Leggi di più